Adderall

A 3:1 mixture of dextra-amphetamine to l-amphetamine is used to treat attention deficit hyperactivity disorder.

History
In the United States, the mixture was approved with a New Drug Application (NDA) by the FDA in 1960. The extended release version was approved in 2001. A generic version (not extended release) was approved with a Abbreviated New Drug Application (ANDA) in 2002.